Cancer Drugs Trigger Heart Failure in Patients, Study Reveals

Researchers tracking cancer patients across the nation found that acute heart failure is a significant complication during treatment, requiring new screening protocols. The finding matters to hospitals, insurers, and pharmaceutical companies working on cancer therapies—it could reshape treatment guidelines and drive demand for cardiac monitoring services.

Originaltitel: Acute heart failure presentation, management, and outcomes in cancer patients: a national longitudinal study